Pharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.
Diane Karns, PhD, RPh, BCSCP
Advertisement
Articles by Diane Karns, PhD, RPh, BCSCP
Advertisement
Latest Updated Articles
More Scrutiny Means Strict Regulation and OpportunityPublished: April 9th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Incidence of VAIs in Patients With Chronic Kidney Disease on Dialysis Relatively Low
4
New Data Suggest Low Risk in Hamster Ovary-Derived Therapies For Alpha-Gal Syndrome
5
